
Interesting Medicines6 min read
Inclisiran & Evolocumab: Different Paths, Same Goal
Two PCSK9-directed strategies, different mechanisms, and different levels of cardiovascular outcomes evidence.
Read articleBrowse Medeasy Review articles focused on Lipids.

Two PCSK9-directed strategies, different mechanisms, and different levels of cardiovascular outcomes evidence.
Read article
Move beyond LDL-C alone toward individualized, risk-based prevention.
Read article